What is ePatientFinder?
Elligo Health Research, operating under the ePatientFinder umbrella, is a key player in clinical trial management solutions. The company leverages advanced technology, including the IntElligo Research Stack, to enhance research efficiency and success. By connecting sponsors with a vast network of healthcare-first and research-only sites, Elligo facilitates patient recruitment and engagement across over 1,000 studies globally. Their core mission is to streamline the clinical trial process, making research more accessible and effective for both patients and sponsors.
How much funding has ePatientFinder raised?
ePatientFinder has raised a total of $13.4M across 3 funding rounds:
Series A
$2.6M
Series B
$8.2M
Debt
$2.6M
Series A (2015): $2.6M, investors not publicly disclosed
Series B (2016): $8.2M, investors not publicly disclosed
Debt (2017): $2.6M, investors not publicly disclosed
What's next for ePatientFinder?
The substantial enterprise-level funding and recent strategic investment signal a strong growth trajectory for ePatientFinder. This capital infusion is expected to fuel further expansion of their clinical trial management platform, enhance technological capabilities, and broaden their reach within the global research community. The company is well-positioned to capitalize on the increasing demand for efficient and patient-centric clinical trial solutions, aiming to solidify its market leadership.
See full ePatientFinder company page
